We are live on ! Find out more
MBOT icon

Microbot Medical

79 hedge funds and large institutions have $34.3M invested in Microbot Medical in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

100% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 13

51% more capital invested

Capital invested by funds: $22.8M → $34.3M (+$11.5M)

13% more funds holding

Funds holding: 7079 (+9)

4.24% more ownership

Funds ownership: 16.96%21.2% (+4.2%)

17% less call options, than puts

Call options by funds: $850K | Put options by funds: $1.03M

Holders
79
Holders Change
+9
Holders Change %
+12.86%
% of All Funds
0.97%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
26
Reduced
13
Closed
11
Calls
$850K
Puts
$1.03M
Net Calls
-$177K
Net Calls Change
-$1.13M

MBOT Hedge Fund Activity: Q1 2026 in Review

79 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2026, worth a combined $34.3M — up 51% from $22.8M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new MBOT positions and 11 closed out — a net gain of 11 holders — while 26 added to existing stakes and 13 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $1.07M. The largest seller was Susquehanna International Group, cutting an estimated $717K.

  • 79 institutional investors held Microbot Medical (MBOT) as of Q1 2026, up from 70 in Q4 2025.
  • Funds reported $34.3M of Microbot Medical stock for Q1 2026, up 51% quarter-over-quarter.
  • 22 funds opened new Microbot Medical positions in Q1 2026 and 11 closed out, a net change of +11 holders.
  • The largest Microbot Medical buyer in Q1 2026 was Marshall Wace, an estimated $1.07M added.
  • The largest Microbot Medical seller in Q1 2026 was Susquehanna International Group, an estimated $717K sold.

Based on aggregated 13F filings for Q1 2026.